GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
September 2022 "Background G protein-coupled receptor (GPCR) is the most targeted protein family by the FDA-approved drugs. GPCR-kinase 3...
top of page
Ecosystem
Beta Site
Blog: Blog2
GPCR News
Search
bottom of page